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The lateralization accuracy of inferior petrosal sinus sampling in Cushing’s disease:
experiences of a tertiary center
1,

1

2

1

1

Elif Tutku DURMUŞ *, Ayşegül ATMACA , Fatih UZUNKAYA , Ramis ÇOLAK , Buğra DURMUŞ 
1
Department of Endocrinology and Metabolism, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Turkey
2
Department of Radiology, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Turkey
Received: 21.03.2022

Accepted/Published Online: 25.08.2022

Final Version: 19.10.2022

Background/aim: The purpose of this study is to determine the accuracy of bilateral inferior petrosal sinus sampling (IPSS) in
lateralization and to investigate variables associated with accurate IPSS lateralization prediction.
Materials and methods: Initially, data from 55 patients who underwent IPSS in our institution were reviewed retrospectively. IPSS
lateralization and pituitary magnetic resonance imaging (MRI) results of these patients were compared with postoperative follow-up
and immunohistochemical data to calculate the positive predictive values (PPVs) for IPSS and MRI. Variables likely to be associated
with the accurate prediction of IPSS lateralization were analyzed.
Results: Twenty-seven patients (85.2% female, mean age of 38.5 ± 13.1 years) were enrolled in the study. With IPSS, interpetrosal
ratios were found to be ≥ 1.4 in 26 (96.2%) cases, and this ratio correctly predicted adenoma localization for 18 patients (PPV: 69.2%).
For 16 (59.2%) patients, right lateralization was detected, while left lateralization was detected for 10 (37%) patients. Right-sided IPSS
lateralization was associated with enhanced accuracy (p = 0.026). No masses were detected in the MRI images of 10 (37%) patients, while
microadenoma of ≤ 6 mm was detected for 17 (63%) patients. MRI results (when positive) correctly identified adenoma localization for
14 of the patients with lateralization accuracy higher than that of IPSS (PPV: 82.3% vs. 69.2%).
Conclusion: IPSS is a valuable procedure in detecting tumor lateralization, especially in patients with Cushing’s disease who have
negative pituitary MRI results. However, since lateralization has a limited reliability, the pituitary gland should be comprehensively
evaluated by taking into account the MRI findings (if positive) as well as data on the side of IPSS lateralization.
Key words: Cushing’s disease, bilateral inferior petrosal sinus sampling, lateralization, magnetic resonance imaging

1. Introduction
Cushing’s disease (CD), the most common cause of
adrenocorticotropic
hormone
(ACTH)-dependent
Cushing’s syndrome (CS), generally results from ACTHsecreting pituitary tumors, but in rare cases, it may also be
caused by ectopic (nonpituitary) ACTH-secreting tumors
[1]. The presence of similar clinical and laboratory findings
for these two conditions may complicate the differential
diagnosis. Further factors complicating the diagnostic
process are as follows: roughly 40% of all ACTH-secreting
pituitary tumors are not revealed by imaging methods and
it is estimated that ≥10% of all individuals in the general
population have incidental microadenomas with small
size and lack of clinical symptoms and signs [2]. This
complex situation has made bilateral inferior petrosal
sinus sampling (IPSS) the gold standard to distinguish
between pituitary and ectopic causes [1]. ACTH levels

measured by IPSS simultaneously from the inferior left
and right petrosal sinuses and peripheral venous drainage
can be directly compared with each other [1, 3]. Based on
previous studies, CD may be diagnosed in the presence of
baseline central-to-peripheral (C/P) gradient ratios above
2 or 3 following the stimulation of corticotropin-releasing
hormone (CRH) and ectopic tumors secreting ACTH can
then be confidently ruled out [1, 4].
IPSS is also used to ascertain on which side the
adenoma is localized in cases of CD, and it can guide the
surgeon during the procedure to be performed [1, 4].
Previous studies reported that the presence of an ACTH
gradient difference of at least 1.4 between the inferior
petrosal sinuses (i.e. comparing the two sides) can be
used to predict the lateralization of adenoma in CD [35]. However, although IPSS has a high diagnostic accuracy
for the localization of the pituitary gland, its reliability
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for tumor lateralization is still controversial. Sometimes,
IPSS lateralization may be incompatible with true tumor
localization due to the effects of venous plexus drainages or
asymmetrical anatomy. The probability that lesions in CD
may be very small and the limited number of tests that we
can perform preoperatively also reveal the need for other
predictors of lateralization accuracy in IPSS. However, the
number of studies conducted on such predictive factors
that may contribute to surgical remission remains very
limited in the literature.
This study was planned to determine the accuracy of
IPSS in the lateralization of pituitary adenoma, compare
that accuracy with the accuracy of positive pituitary
magnetic resonance imaging (MRI) findings, and evaluate
whether there is a need for other factors predicting the
lateralization accuracy of IPSS by taking advantage of our
experiences with IPSS in our institution.
2. Materials and methods
2.1. Study design and participants
In this study, we retrospectively evaluated the data of 55
patients diagnosed with ACTH-dependent CS between 2010
and 2019 who underwent IPSS for differential diagnosis in
the interventional radiology department of our institution.
All patients met the diagnostic criteria for CS as given in
the clinical practice guidelines of the Endocrine Society [6].
Twenty-eight patients were excluded from the study, 3 of
whom were diagnosed with ectopic CS according to IPSS
results, 12 of whom were not followed after the decision
for an operation due to the diagnosis of CD, 8 of whom
were not operated on due to follow-up decisions regarding
subclinical CS, 4 of whom preferred an external medical
center for their operations, and 1 of whom was not followed
after the operation. Thus, 27 patients were enrolled in the
study, all of whom had a diagnosis of CD as confirmed
by IPSS, underwent transsphenoidal hypophysectomy in
our hospital, and admitted regularly for their follow-up
examinations. Standard diagnostic test results for patients
with CS [serum cortisol (µg/dL), serum ACTH (pg/mL),
midnight serum cortisol (µg/dL), 24-h urinary free cortisol
(UFC), dehydroepiandrosterone sulfate (DHEAS), 1 mg
dexamethasone suppression test (DST), low-dose 2-day
dexamethasone test (LDDT), and high-dose (8 mg) DST)]
were recorded. All patients were assessed with pituitary
MRI before IPSS. IPSS indications were either a normal
pituitary MRI result or adenoma of ≤6 mm in patients
biochemically diagnosed with ACTH-dependent CS [1].
The IPSS procedures were performed in the Interventional
Radiology Department of our institution. All patients were
comprehensively informed about the risks, benefits, and
potential complications of the IPSS procedure before it
was performed and informed consent was obtained from
the patients before the procedure. CRH was administered

to all patients during IPSS. Central/peripheral (C/P) ratios
for ACTH levels were checked at the beginning, during
IPSS, and after CRH injection, and right/left (R/L) ratios
for ACTH levels before and after CRH administration were
recorded. The ACTH ratios were calculated for peripheral
venous blood samples from the left and right inferior
petrosal sinuses at all time points (C/P values). IPSS results
were accepted as providing a positive diagnosis for pituitary
production of ACTH if the peak ratio measured after
administering CRH was >3 [4]. Interpetrosal gradient ratios
were additionally determined between the two petrosal sinus
samples obtained at each considered time point and these
ratios were taken to be predictors of lateralization at values
of >1.4 [4-6]. Before undergoing operation, all patients were
evaluated with clinical and preoperative imaging findings
and IPSS results during meetings of the pituitary council,
which were also attended by endocrinology, neurosurgery,
endocrine pathology, and neuroradiology specialists,
as well. According to the evaluation performed during
the meeting of this council, patients were operated on by
a neurosurgeon experienced in pituitary surgery, who
performed adenomectomy and/or hemihypophysectomy
using the transsphenoidal microsurgery technique. Those
with postoperative serum cortisol concentrations of <2 µg/
dL were considered to be in remission and glucocorticoid
replacement was performed during their follow-up for
treatment of the hypothalamic-pituitary-adrenal (HPA)
axis [1, 7]. The exact location of the mass was determined
by evaluating the immunohistochemical and postoperative
follow-up results (remission/persistent disease) of the
patients, and those results were then compared with the
preoperative IPSS lateralization and pituitary MRI results.
The study was granted approval by the relevant institutional
ethics committee (OMU KAEK 2019/480).
2.2. Assay
Cortisol levels were measured by competitive
electrochemiluminescent immunometric assay using the
Cobas 8000 Modular Analyzer Series (Roche Diagnostics).
For the cortisol assay, analytical sensitivity was 0.018 µg/
dL and the intraassay coefficient of variation (CV) was
1.5%–1.7%. ACTH and DHEAS levels were measured
by solid-phase two-site sequential and competitive
chemiluminescent immunometric assays, respectively,
using the IMMULITE 2000 Immunoassay System
(Siemens Healthcare Diagnostics). For the ACTH assay,
analytical sensitivity was 5 pg/mL, intraassay CV was
8.7%–9.5%, and interassay CV was 6.1%–10%. For the
DHEAS assay, analytical sensitivity was 3 µg/dL, intraassay
CV was 4.9%–9.8%, and interassay CV was 7.9%–13%.
After urine extraction with dichloromethane, 24-h UFC
was measured by the electrochemiluminescent technique
with intra- and interassay CVs of 1.5%–1.7% and 1.8%–
2.2%, respectively.
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2.3. Imaging protocol
MRI examinations were performed using the same
pituitary MRI protocol for all patients with a 1.5-T Siemens
MR unit (Magnetom Symphony Quantum, Siemens
Medical Systems) or 1.5-T Philips MR unit (Achieva;
Philips Healthcare). T1-weighted and T2-weighted spin
echo sequences were obtained with a slice thickness of 3
mm for the coronal and sagittal planes. Later, T1-weighted
turbo spin echo dynamic sequences were obtained with
3-mm slice thickness for the coronal and sagittal planes
after gadolinium injection (0.1 mmol/kg).
2.4. Catheterization protocol
Under ultrasonographic guidance, 5-Fr introducer sheaths
were placed in both common femoral veins. Subsequently,
2500 U of heparin was administered intravenously to
avoid thrombotic complications. Habitually starting from
the right side, a vertebral shaped 4-Fr diagnostic catheter
was advanced over a hydrophilic guidewire to cannulate
the orifice of the ipsilateral inferior petrosal sinus using
the internal jugular vein route. By hand injection of
iodinated contrast medium, the anatomy of the right
inferior petrosal and cavernous sinuses as well as that of
the intercavernous sinus were revealed with the patient in
supine position, and fluoroscopic images were recorded.
The same procedure was thereafter conducted for the
left side (Figure). In the event of failure to cannulate any
orifice, contralateral road-mapping was performed to
discover the entry point. Right or left oblique projections
were used if this action did not make cannulation possible.

Upon catheterization of the bilateral inferior petrosal
sinuses, a blood sample of 2 mL was simultaneously taken
at 0 min from both catheters as well as from the introducer
sheath on the right or left side to measure basal ACTH
levels. Simultaneous samplings were repeated at 3, 5, 8, 10,
and 15 min following intravenous CRH injection (1 µg/kg
up to 100 µg maximal dose). Blood samples were stored
in pre-labeled EDTA tubes and sent to the laboratory on
ice. These procedures were ended with bilateral groin
hemostasis following the withdrawal of the catheters.
2.5. Statistical analysis
While analyzing descriptive statistics, continuous
variables were given as median [with range or
interquartile range (IQR)], while categorical variables
were given as frequency (with percentage). The normality
of the data was evaluated with the Kolmogorov-Smirnov
test. Independent categorical variables were compared
using chi-square or Fisher’s exact tests, while dependent
categorical variables were compared using the McNemar
test. Nonparametric data were compared using the
Mann-Whitney U test. In the process of determining the
rates of lateralization accuracy, positive predictive values
(PPVs) were obtained with the following calculation
for the interpetrosal gradient as measured by IPSS and
pituitary MRI results: count of true positive results
obtained for the test / (count of true positive results +
count of false positive results). All statistical comparisons
were two-tailed and values of p < 0.05 were considered to
be statistically significant.

Figure. Fluoroscopic image showing the contrast filling both
cavernous sinuses, as well as the intercavernous sinus (*). Note
that the tips of the diagnostic catheters (arrows) are located in
the orifices of the bilateral inferior petrosal sinuses.
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3. Results
Of the 27 patients enrolled in this study, 23 (85.2%) were
female and 4 (14.8%) were male, with a mean age of 38.5 ±
13.1 (18–65) years and a mean follow-up period of 42.5 ±
30.4 months. At the time of diagnosis, the median serum
cortisol level of the patients was found to be 21.9 (13.0–
25.8) µg/dL (normal range: 6.2–19.4 µg/dL), while median
plasma ACTH was 65.8 (45.4–96.0) pg/mL (normal
range: < 46 pg/mL), and low-dose 2-day DST results
could not be suppressed for any patients. All preoperative
endocrinological test results of the patients, obtained prior
to the bilateral IPSS results, are shown in Table 1.
For all patients, C/P ratios obtained by IPSS were >2 at
baseline and >3 after CRH injection. Interpetrosal ratios
were ≥1.4 for 26 patients (96.2%), while it was <1.4 for 1
patient and lateralization could not be detected (Table 2).
IPSS correctly predicted the side of the pituitary gland
that contained the adenoma in 18 (69.2%) of these 26
patients with lateralization, while the adenoma was located
contralaterally in 8 cases (30.8%) (Table 3). According
to these results, PPV was considered to be 69.2% for
lateralization in IPSS. IPSS lateralized the right side in
16 (59.2%) cases and the left side in 10 (37%) cases. The
accuracy rate for right lateralization was found to be
significantly higher than that for the left side (p = 0.026)
(Table 4). When evaluated based on the CRH stimulation
response pattern, 22 (84.6%) patients with lateralization
were found to have consistent lateralization (interpetrosal
ratio of ACTH levels prior to and after CRH administration
of ≥1.4), while 3 patients (11.5%) had lateralization
only before CRH administration and 1 (3.8%) patient
had lateralization only after CRH administration. The
PPV was found to be 68.1% for patients with consistent
lateralization, while it was 75% for other CRH stimulation
response patterns. The IPSS lateralization accuracy rates

for variables other than side of lateralization [pattern of
response to CRH, peak interpetrosal gradient ratio, peak
interpetrosal gradient ratio time (before or after CRH
administration), age, sex, MRI positivity, and ratio 0’ (right/
left ratios for ACTH levels prior to CRH administration)
and ratio max (right/left ratios of ACTH levels following
CRH administration)] were similar to each other (Table 4).
No thromboembolic or any other complications associated
with the IPSS procedure were observed among our patients.
No mass was detected by pituitary MRI for 10 (37%)
patients, while MRI results were positive for adenoma
in 17 (63%) cases. For 9 of 10 patients with negative
pituitary MRI results, lateralization was detected by
IPSS, with IPSS showing the lateralization correctly in 6
(66.7%) of the cases. For the remaining MRI-negative
patient, IPSS showed no lateralization due to bilateral
adenoma and a total hypophysectomy was performed.
For cases in which the results of pituitary MRI suggested
the presence of adenoma, the location of the adenoma
was accurately revealed by the imaging results of 14 of 17
patients (PPV: 82.3%). Compared to the accuracy of IPSS
for lateralization of adenoma, MRI (when positive) had
proportionally higher accuracy (PPV: 69.2% vs. 82.3%).
By the results of immunohistochemical examinations, 20
(74.1%) patients had corticotropic adenoma and 1 (3.7%)
patient had gonadotropic adenoma, while no evidence of
pituitary adenoma was obtained for 6 (22.2%) patients.
Remission was achieved after surgery for 19 (70.4%) of
the patients, while remission could not be achieved in 8
(29.6%) cases. In 3 patients (11.1%), who initially showed
remission, recurrence developed during follow-up. Table
3 summarizes the demographic characteristics of these
patients, preoperative MRI findings, IPSS lateralization
results, surgical and histopathological data, and
postoperative follow-up results.

Table 1. Preoperative endocrinological test results of the patients prior to bilateral inferior
petrosal sinus sampling.
Hormonal values

Median (IQR)

Cortizol (6.2–19.4 µg/dL)

21.9 (13.0–25.8)

ACTH (0–46 pg/mL)

65.8 (45.4–96.0)

UFC (10–100 µg/dL)

476 (135.4–795.0)

Midnight serum cortizol (2.3–11.9 µg/dL)

16.7 (12.4–21.1)

DHEAS (35–430 µg/dL)

294 (160.0–392.0)

1 mg DST (µg/dL)

11.7 (8.2–21.3)

Low-dose 2-day DST (µg/dL)

6.7 (4.2–15.7)

High-dose DST (µg/dL)

3.4 (1.7–5.9)

ACTH: adrenocorticotropic hormone, DHEAS: dehydroepiandrosterone sulfate, DST:
dexamethasone suppression test, UFC: 24-h urinary free cortisol.
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Table 2. Lateralization of the adenoma according to bilateral inferior petrosal sinus sampling and ratios.
Case

C/P ratio 0’

C/P ratio max.

Lateralization

Ratio 0’

Ratio max.

1

12.3

9.2

L

2.1

1

2

11.5

15.4

R

7.4

8.7

3

26.6

16

R

5.2

5

4

5

13.2

R

1.3

8.6

5

5.6

20.1

R

11.6

3.4

6

9.4

9.3

R

8.4

7.9

7

6.5

23.1

R

5.8

19.7

8

18.3

13.2

R

8.1

1

9

22.5

23.3

R

18.5

1.4

10

19.3

20.2

L

18.3

14

11

2.3

7.2

L

3

3.3

12

18.9

12.8

R

14.7

6.4

13

14.5

14.7

R

9

12

14

9.7

8.4

R

7.1

3.3

15

2.8

7.9

L

5.1

1.6

16

21.4

11.5

R

2

1

17

30.4

16.4

L

25

13

18

26

9.7

L

10.2

4.4

19

22

17

L

19

12

20

8.2

10

L

6.6

5.7

21

15.2

22.3

R

11.4

18.3

22

10.8

28.7

R

12

22.8

23

6.5

5.8

L

2,3

3

24

4.9

6.5

L

5

4.9

25

21.6

21.5

R

2.4

14.1

26

1.8

8.4

R

1.5

6.4

27

10.1

5.8

R+L

1

1

C/P: central/peripheral, C/P ratio 0: initial C/P ratios for ACTH levels, C/P ratio max: C/P ACTH levels after CRH
injection, Ratio 0’: right/left ratios for ACTH levels prior to CRH administration, Ratio max: right/left ratios of
ACTH levels following CRH administration.

4. Discussion
This study has revealed that IPSS had a PPV of 69.2%
for lateralization (i.e. right or left side) of tumors in a
sample of patients with CD, with a higher rate of accuracy
obtained for tumors located on the right side. Additionally,
the accuracy rate of positive pituitary MRI results for the
localization of these adenomas was found to be 82.3%.
Thus, compared to the PPV of IPSS, MRI (when positive)
was more accurate in its ability to predict the locations of
tumors of the pituitary gland.
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Previous studies assumed that asymmetric, hypoplastic,
or plexiform petrosal sinus anatomy could cause false
lateralization results by IPSS together with catheter
positioning and the petrosal collateral venous drainage of
the sinuses [3, 5, 8-10]. It is a common belief that, due to
the potential impact of all these variables, there may not be
a conclusive evidence that an appropriate pituitary blood
sample can be drawn from both inferior petrosal sinuses
even if the catheters are positioned correctly. In support
of this opinion, the accuracy range of lateralization of
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Table 3. Demographic characteristics, preoperative magnetic resonance imaging findings, bilateral inferior petrosal sinus sampling
lateralization results and accuracy, surgical approach, histopathological findings, and clinical follow-up results of patients.
Tumor localization

Case S/A

MRI

IPSS
Actual Surgery
(lat)

Pathology

Clinical
Accuracy Accuracy
follow-up
of IPSS
of MRI
results

1

F/28

R, 2.5 mm ma

L

R

RA

CA

False

True

Remission

2

F/51

L, 3 mm ma

R

L

LA

CA

False

True

Remission

3

F/64

L, 6 × 4 mm ma

R

L

TH

G+CA

False

True

Remission

4

F/44

R, 5 mm ma

R

R

RA

CA

True

True

Remission

5

F/38

R, 6 × 3 mm ma

R

R

RA

CA

True

True

Remission

6

F/46

L, 6 × 4 mm+R, HCE

R

R

RHH+LA

NTA

True

False

Remission

7

F/21

HCE

R

R

RHH

CA

True

-

Remission

8

F/53

Empty sella

R

R

RHH

CA

True

-

Remission

9

F/31

R, 5 mm ma

R

R

RA

CA

True

True

Remission, Rec-Reop

10

F/43

L, 6 × 5 mm ma

L

L

LA

CA

True

True

Remission, Rec-GK

11

F/32

L, 5 × 3 mm ma

L

R

LA

NTA

False

False

No Remission, Reop

12

F/65

R,5 × 4+L,3 × 4 mm ma R

R+L

RA+LA

Bilateral CA

True

True

Remission

13

M/43 R, 6 × 4 mm ma

R

R

RA

CA

True

True

Remission

14

F/32

HCE

R

R+L

RHH

CA

True

-

No Remission, Reop

15

M/36 L, 4 mm ma

L

R+L

LA

CA

True

True

No Remission, Reop

16

F/31

R, 3 mm ma

R

R

RA

CA

True

True

Remission, Rec-Reop

17

F/25

HCE

L

L

LHH

CA

True

-

Remission

18

F/36

HCE

L

R

LHH

NTA

False

-

No Remission, Reop-GK-med

19

F/18

Normal

L

R

LHH

NTA

False

-

No Remission, Reop-med

20

M/41 HCE

L

R

LHH

NTA

False

-

No Remission, Reop-med

21

F/25

L, HCE

R

R

LHH

NTA

True

-

No Remission, Reop-med

22

F/18

R, 6 × 5 mm ma

R

R

RA

CA

True

True

Remission

23

F/46

L,3 mm ma

L

L

LA

CA

True

True

Remission

24

M/26 R, 6 × 3.5 mm ma

L

R

RA

CA

False

True

Remission

25

F/60

L, 6 × 5 mm ma

R

R

LA

GA

True

False

No Remission

26

F/41

HCE

R

R

RHH

CA

True

-

Remission

27

F/48

HCE

-

R+L

TH

Bilateral CA

-

-

Remission

Accuracy: lateralization accuracy of inferior petrosal sinus sampling, CA: corticotroph adenoma, F: female, S/A: sex/age, G: gangliocytoma,
GA: gonadotroph adenoma, GK: gamma knife therapy, HCE: heterogeneous contrast enhancement, IPSS: inferior petrosal sinus sampling, L:
left, Lat: lateralization, LA: left adenomectomy, LHH: left hemihypophysectomy, M: male, ma: microadenoma, med: medical therapy, MRI:
magnetic resonance imaging, N/A: not available, NTA: nontumoral adenohypophyses, R: right, RA: right adenomectomy, Rec: recurrens,
Reop: reoperation, RHH: right hemihypophysectomy, TH: total hypophysectomy.
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Table 4. Patient variables associated with accurate IPSS lateralization prediction.
Variable

PPV present (%)

PPV absent (%)

p value

Consistent lateralization

15 (83.3)

7 (87.5)

1.00

Others*

3 (16.7)

1 (12.5)

Right

14 (77.8)

2 (25.0)

Left

4 (22.2)

6 (75.0)

Peak interpetrosal gradient ratio

11.8 (7.1–18.3)

5.9 (4.1–9.4)

0.107

Before CRH administration

10 (55.6)

6 (75.0)

0.420

After CRH administration

8 (44.4)

2 (25.0)

Age

40 (31–46)

34 (27–46)

0.656

Sex, female

16 (88.9)

6 (75.0)

0.563

MRI positivity

10 (83.3)

4 (80.0)

1.00

Ratio 0’

8.2 (2.4–12.08)

5.9 (4.0–8.8)

0.579

Ratio max.

7.1 (3.0–14.0)

4.9 (3.8–7.2)

0.404

Response pattern to CRH

Side of lateralization
0.026

Peak interpetrosal gradient ratio time

CRH: corticotropin-releasing hormone, IPSS: inferior petrosal sinus sampling, MRI: magnetic resonance
imaging, Ratio 0’: right/left ratios for ACTH levels prior to CRH administration, Ratio max: right/left ratios of
ACTH levels following CRH administration,
*Others: lateralization only before CRH administration and Lateralization only after CRH administration.

adenomas in cases of CD by IPSS was reported in a wide
range of 48%–84% in the literature [3-5, 11]. Another
issue that may contribute to differences in results is the
fact that in some studies CD remission alone and in others
positive immunohistochemical analysis alone is taken
as a basis in determining the accuracy of lateralization.
The inclusion of only histopathologically verifiable cases
in the study and the exclusion of cases of remission after
treatment from evaluation may cause IPSS lateralization
accuracy results to seem lower. This is because the lesions
in CD can be very small and losses may therefore develop
due to surgical intervention. In our study, we determined
the lateralization accuracy to be 69.2% with the aim of
minimizing selection bias and being able to evaluate
lateralization reliability more accurately, while also taking
into account the consequences of postoperative remission/
persistent disease in immunohistochemical evaluation
and follow-up. In a study that enrolled 501 patients with
CD with the aim of determining the reliability of IPSS in
lateralization by calculating PPV values, similarly to our
study, IPSS results accurately revealed which side of the
pituitary gland harbored the tumor in 273 cases (69%),
while contralateral tumor location was subsequently
identified in 123 cases (31%) [3]. Other researchers
concluded that the results of bilateral IPSS for pathology-
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proven cases were consistent with those of pathologic
lateralization for approximately 50% of the patients
enrolled in the study [11]. In another study, accuracy
rates were evaluated among patients for whom surgical
lateralization of the tumor was confirmed to be either right
or left, disregarding the results of lateralization by IPSS,
and a fairly low accuracy rate of 54% was obtained [12].
Due to the limited examination possibilities for
accurately determining the localization of adenoma in
cases of CD, factors that may predict the accuracy of IPSS
lateralization, the reliability of which is still a matter of
debate, are important. However, studies in the literature
on factors associated with lateralization accuracy are quite
limited and give conflicting results. Wind et al. concluded
that findings of left-sided IPSS lateralization and concordant
lateralization results obtained preceding and following the
administration of CRH both correlated with higher levels
of accuracy [3]. However, Feng et al. reviewed 51 cases to
ascertain whether or not lateralization results obtained by
IPSS were similar to those obtained by surgery, and the
cases in the group with concordant results were found to
have a higher rate of right lateralization in the process of
surgical exploration (p = 0.020) [13]. There was a higher
frequency of right-sided lateralization in our study, as well,
and right-sided lateralization results obtained by IPSS
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were found to be related to higher rates of accuracy. This
could be understood in the context of asymmetrical venous
drainage resulting from assorted possible anatomical
variations, as noted in previous research [5, 9]. Some studies
have revealed inconsistent ACTH concentration values
between IPSS results, even among healthy individuals [14].
Accordingly, it is clear that asymmetric venous drainage is a
relatively common finding for the bilateral inferior petrosal
sinuses and this fact must be considered whenever IPSS
is being performed [13]. Studies showing that choosing
patients with symmetrical venous drainage is likely to
increase the accuracy of lateralization support this claim,
as well [5, 9]. It is clear that future studies conducted on this
issue while considering venous drainage patterns will give
more reliable results.
With pituitary MRI, only about 50% of microadenomas
can be clearly shown because most ACTH-secreting
pituitary adenomas are very small in size [15]. In
addition, the current guidelines are in consensus that
IPSS is necessary for all patients with lesions of ≤6 mm
or negative MRI results while patients with lesions of ≥10
mm do not need IPSS because a pituitary lesion detected
by MRI may be an accidental sellar mass and the source of
ACTH may be ectopic [1]. In the literature, however, data
on the reliability of MRI positivity in adenoma localization
may be affected by the presence of microadenomas being
≤6 mm among the selection criteria for IPSS, with rates
consequently detected to be lower than they really are. In
the present study, IPSS was less reliable in lateralization
than MRI (when positive), with PPVs of 69.2% and 82.3%,
respectively. Previous studies have demonstrated findings
similar to these regarding the advantages of pituitary MRI
over IPSS considering the results for lateralization, with
PPVs reported as 86% vs. 69%, 75% vs. 48%, and 70% vs.
63%, respectively [3, 11, 16]. These results support the idea
that MRI is likely to have a higher reliability compared
to IPSS in cases of tumor lateralization. However, in
our study, localization was found to be correct for 6 of
9 patients (66.7%) with negative pituitary MRI results
whose lateralization could be determined by IPSS. Thus,
these patients were prevented from undergoing total
hypophysectomy. In this regard, it is clear that IPSS
does have a considerable clinical significance regarding
lateralization, especially when pituitary MRI results are
negative.
IPSS is generally a safe procedure; most complications
reported in the literature have involved inguinal hematomas
and thromboembolic complications are rare [17]. No
complications developed during or after the sampling
procedure in our tertiary center. In particular, probably
thanks to a protocol entailing routine administration of
heparin, the most feared complications for this procedure,
namely thromboembolic complications, were not observed
in any cases in our center.

The limitations of our study are due to the low
number of patients that could be evaluated as a result of
the retrospective study design, as well as the lack of data
for postoperative follow-up. The application of IPSS only
for patients with insufficient and suspicious imaging
results causes selection bias arising from limitations
in patient selection and the inability to select a random
sample. In addition, since CRH stimulation is applied to
all of our patients in the procedure for IPSS, it must be
noted that our results may only be applicable to patients
for whom CRH stimulation is applied in the course of
IPSS. On the other hand, in addition to determining the
reliability of IPSS in lateralization in this study, we have
evaluated possible factors that may affect the reliability
of lateralization, a topic for which limited data are
available in the literature, and we have also confirmed the
existence of higher rates of accuracy for cases of rightsided lateralization. In addition, we have ascertained that
pituitary MRI (when positive) is more reliable than IPSS
in the accurate prediction of adenoma lateralization. We
are of the opinion that our results represent an important
contribution to the literature, to daily practice, and to
ensuring correct preoperative determination of tumor
localization in patients with CD.
Our study shows that IPSS is a useful, safe application
that can guide surgical exploration, especially in cases
where imaging possibilities are inadequate. However,
if the results are positive, it should be considered that
the reliability of pituitary MRI for lateralization may be
higher than that of IPSS. Because of the limited accuracy
of IPSS in lateralization, the possibility of results of rightsided lateralization predicting the accuracy of IPSS in
lateralization should be evaluated further.
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